Rein Therapeutics Inc. (RNTX)
NASDAQ: RNTX · Real-Time Price · USD
1.390
-0.050 (-3.47%)
At close: Oct 8, 2025, 4:00 PM EDT
1.380
-0.010 (-0.72%)
After-hours: Oct 8, 2025, 5:42 PM EDT
Rein Therapeutics Market Cap
Rein Therapeutics has a market cap or net worth of $32.39 million as of October 8, 2025. Its market cap has decreased by -59.91% in one year.
Market Cap
32.39M
Enterprise Value
26.67M
1-Year Change
-59.91%
Ranking
Category
Stock Price
$1.39
Market Cap Chart
Since June 29, 2017, Rein Therapeutics's market cap has decreased from $158.90M to $32.39M, a decrease of -79.61%. That is a compound annual growth rate of -17.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2025 | 33.60M | -32.53% |
| Dec 31, 2024 | 49.80M | 260.87% |
| Dec 29, 2023 | 13.80M | 27.78% |
| Dec 30, 2022 | 10.80M | -78.82% |
| Dec 31, 2021 | 51.00M | 20.57% |
| Dec 31, 2020 | 42.30M | 166.04% |
| Dec 31, 2019 | 15.90M | 28.23% |
| Dec 31, 2018 | 12.40M | -92.01% |
| Dec 29, 2017 | 155.10M | -2.39% |
| Jun 29, 2017 | 158.90M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 758.63B |
| Johnson & Johnson | 453.15B |
| AbbVie | 406.64B |
| UnitedHealth Group | 324.93B |
| Novo Nordisk | 269.41B |
| AstraZeneca | 265.89B |
| Novartis AG | 257.47B |
| Abbott Laboratories | 232.77B |